Athira Pharma Inc

Research Athira Pharma Inc (LONA) on Bullrun: market cap USD 83.23M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerLONA
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 83.23M
• Financial periodFY2025
• Net income-USD 106.00M

Valuation Snapshot

latest market cap is USD 83.23M.

About Athira Pharma Inc

LeonaBio, Inc., clinical-stage biopharmaceutical company, engages in the development of novel therapeutics for high unmet medical needs, including treatment-resistant metastatic breast cancer and amyotrophic lateral sclerosis. The company's lead products include lasofoxifene and ATH-1105, a novel small molecule therapies with the potential to address devastating diseases where current treatment options are limited or ineffective.

Frequently asked questions

What is Athira Pharma Inc's market cap?

Athira Pharma Inc's market capitalization is USD 83.23M.

What does Athira Pharma Inc do?

LeonaBio, Inc., clinical-stage biopharmaceutical company, engages in the development of novel therapeutics for high unmet medical needs, including treatment-resistant metastatic breast cancer and amyotrophic lateral sclerosis.